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Substance P is an undecapeptide found in multiple sites 
throughout the central and peripheral nervous systems in-
cluding small unmyelinated (type C) cutaneous nerve fi-
bers. Previous studies demonstrated that antidromic stim-
ulation results in substance P (SP) release from nerve endings, 
.SP stimulates histamine release (HR) from rat mast cells in 
vitro, and intradermal SP in humans produces wheals iden-
tical to those induced by histamine. These studies suggest 
a possible role for SP as a link between neurologic events 
and cutaneous mast cell-mediated reactions. We therefore 
investigated SP-induced HR in an in vitro preparation of 
human skin mast cells. 
I n 1931, von Euler and Gaddum [1] announced their discov-ery of an alcoholic extract derived from equine brain and intestinal tissues. This extract induced hypotension and po-tent contractility of intestinal smooth muscle. The addition of sulfuri c ' acid to this extract produced a precipitate that, 
when removed, dried, and powdered, was capable of inducing 
the same biologic effects . This precipitate, designated "standard 
preparation P," is now known as substance P. In 1971 the chem-
ical structure of this undecapeptide was finally elucidated by Chang 
and colleagues [2] and subsequently synthesized by Tregear et al 
[3]. 
Substance P (SP) is predominantly found in the central and 
peripheral nervous systems and in the gastrointestinal tract. Smaller, 
but still significant, amounts are found in multiple other tissues 
[4] . Of interest to dermatology is its presence in primary sensory 
cutaneous neurons, both centrally (dorsal root ganglia) and in the 
distal nerve terminals [5] . 
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Abbreviations: 
EGT A: ethylencglycol-bis-(,B-aminoethylether-N, N' -tetraacetic 
acid 
HR: histamine release 
SP: substance P 
Human foreskin sections were incubated with varying 
concentrations of SP. Histamine was assayed using auto-
mated fluorimetry and release was calculated as a percent-
age of total tissue histamine. Substance P caused dose-
dependent HR over a range from 10 - 5 M (1.3%) to 5 X 
10 - 4 M (25 .1 %). Histamine release was optimal at 3 mM 
calcium and was blocked by pretreatment with calcium 
chelation . Naloxone failed to block HR. 
These studies suggest that HR from skin mast cells by 
SP may playa role in neural modulation of poorly under-
stood inflammatory skin conditions. J In.vest Dermatol 88: 
682-685, 1987 
In 1927, Lewis [6] demonstrated that the axon flare component 
of the triple response was due to arteriolar vasodilatation, which 
in turn was dependent on an intact neural network within the 
skin. In 1953, Lembeck [7] proposed that SP may be a primary 
sensory neurotransmitter. Jancso and coworkers later established 
that the inflammatory response to several topically applied sub-
stances, including capsaicin (an SP-depleting agent), is neuro-
genically mediated, and again included SP as a potential mediator 
of cutaneous vasodilatation [8-10]. In 1981, Bernstein et al showed 
that topically applied capsaicin resulted in the inhibition of axon 
reflex vasodilatation [11] . Foreman [12] has since reviewed evi-
dence implicating SP as the mediator for the axon flare . 
Numerous studies have sought to link SP to the skin, and 
specifically to histamine release (HR). Johnson and Erdos [13] 
showed that SP caused HR in an in vitro preparation of rat peri-
toneal mast cells. Later, an SP analog (D-Pr04, D-T rp7.9. IO SP 4 - II) 
used in low concentrations was shown to partially inhibit mast 
cell release of histamine [14]. 
Experiments involving intradermal SP have repeatedly dem-
onstrated its ability to produce a wheal and flare reaction in hu-
mans [15-18]. Additionally, the flare component is inhibited by 
pretreatment with H-1 antagonists [15-18], doxantrazole (a pu-
tative mast cell stabilizer) [17,18], compound 48/80 [15] , local 
anesthetics [19], and capsaicin [18]. This reaction is also blocked 
by recent intradermal SP injection (tachyphylaxis) [17,18]. In con-
trast, the flare is not blocked by a constricting band placed adjacent 
to the intradermal injection site, w hich implicates neural rather 
than vascular spread (17,18]. 
Severa l studies have examined the effect of antidromic (ret-
rograde) stim ulation of sensory neurons in animals. Following 
electrical stimulation of the saphenous or trigeminal nerves of 
rats, a sharply circumscribed area of vasodilatation occurs cor-
responding to the distribution of the stimulated nerve [8-10]. 
This occurs in both normal and sympathectomized animals [20]. 
Depletion of SP-like immunoreactivity and degranulation of mast 
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cells in the dental pulp of ca ts fo llowing antidromi c stimulation 
of the inferior alveolar nerve [211 has also been reported. 
We h a ve been interes ted in possibl e mechanisms to ex plain the 
c1 inicall y observed and experimentall y docum ented st ress-in-
duced flarin g of atopic dermatitis [22]. Our investigations have 
uti li zed a n in vit ro preparation of human cutaneous mas t cells to 
study the characteristics of SP-induced HR . We have uscd thi s 
mod e l to determine the time course of HR and the effect of 
calciuHl concentration. Addition all y, beca use of studies indica ting 
naloxone/ SP antagonist activity in the central nervou s systcm 
[23,24] a nd o ther studies indi ca tin g that naloxone may be an 
effective antipruriti c agent [25,261. we assessed naloxone antag-
onism of SP-induced HR in our sys tem. 
MATERIALS AND METHODS 
Human Foreskin Preparation Freshly excised in fa nt foreskins 
were placed in specimen tubes (Corning # 25330, Cornin g, New 
Yo rk) containing Dulbecco's modified Eagle's med ium (G IBCO 
Lab s, G rand Island, New York) and 1 % antimicro bic so lutio n 
(G IBCO Labs). All sa mples were processed within 4 h of excision 
beginnin g with the division of each foreskin into 8-12 fragments 
of sin1.ilar size. Each fragment was then sectioned into 200-l1-m 
strands w ith a Sorva ll TC-2 t issue sectioner as described by Tharp 
et a l [27] . The sectioned tissue from each fragment was then 
transfer r ed to a 12 X 100 mm polypropylene tube and was hed 3 
times in 3 ml of buffer containing 135 mM Na C I, 3.8 mM KC I, 
2.5 mM NaH 2P04 , 5.6 mM dextrose, 0. 1 mg/ ml hum an serum 
albumin (Fraction V, Sigma, St. Lo uis , Missouri) , and 2.0 mM 
HEPES, pH 7.20 . 
Substance P-Induced HR After washing, the skin sli ces were 
suspended in 1.0 ml of buffer containin g 3 mM calcium (calcium 
buffer) a nd in cubated at 37"C for 30 min in 3 shaker bath . T he 
supernatant was aspirated fro m each tube and sto red at - 70°C 
until histamine assay . This initi al supernatant was utili zed to de-
terrnine spontaneous HR. 
Specimens were then res uspended in 1.0 1111 of calcium buffer 
(co ntrol s) or various concentrations of SP (Penin sula Labs, Bel-
mont , California) in ca lcium buffer. After another 30-min in-
cubatio n at 37°C, the supernatant was as pirated and frozen. This 
supernatant was used to determine SP-induced HR. 
To d etermine the residual histamine content of each sectioned 
fragmen t, the tissue pellet from e:lch tube was resuspended in 
deionized water (hypoton ic), boiled for 10 min , freeze/thawed, 
and homogenized with a polytron homogenizer. The suspension 
was the n centri fuged at 800 g for 5 min and the supern ata nt 
aspirated and frozen. 
Spon t aneous release from each foreskin fragment was deter-
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Figure 1. Percent HR from human skin mas t ce lls with increasin g con-
centrations of SP. Points indicate mean ± SEM with the Ilumber of 
samples indicated in parentheses . 
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Figure 2. Effect of incubation rime on SP (10- .1 M)-indu ced HI, in human 
skin mast ce ll preparations. Points indica te mean ± SEM with the number 
of sa mples indica ted in parentheses. 
min cd fro m incubations in buffer prior to challenge with SP. 
Spontaneous release valu es grea ter than 15% w cre rega rded as 
un acceptable. Unless o th erw ise stated , the data (Fig 1) represent 
net HR (i.e., the diffcrcn ce between spontaneous release and SP-
induccd HR) for each foreskin frag ment. The mcan spontaneo us 
release o f all specimens was 10.3% ± 1. 0 (SE M) (n = 109). 
The time course of SP-induced HR was determined by incu-
batin g the skin fragments with 10- '\ M SP (a subm aximal hista-
mine-releas ing concentration) for 15, 30, and 60 min (Fi g 2) (fol-
lowing their 30-min incubation in buffer for spontaneous release) . 
Calcium Dependency The effect of ca lcium concentration on 
SP-induccd Hi<. was determined by incubating the m ast cell prep-
ara tions w ith a sin gle subm 3ximall y stimulatin g concentration o f 
SP (1 0 - .1 M) supplementcd w ith vary in g concentrations of CaCI2 
(Fig 3). In additi on, 2 forcskin preparations were pret rea ted with 
EGT A 0. 1 mM (Sigma) [cthyleneglycol bis-((3-amin oethylether)-
N , N'-tet raacetic acid] prior to incubation w ith 10- '\ M SP. 
Naloxone Effect After in cubat ion for 30 min in calciulll buffer 
to determine spontaneous release, dupli ca te fra g ments fr0111 the 
sa me fores kin were further incubated in 0.5-ml aliquots of: (I ) 
calcium buffer (negative control) for 60 min; (2) ca lciu m bt.:ffer 
for 30 min fo ll owed b y 0.5 ml SP 2 X 10- 4 M w ithout rem ovin g 
the supernatant until the tota l 60-min incubation w as co mplete; 
(3) nal oxone hydrocho lo rid e (Dupont, Wilmington, Delaware) 2 
X 10- -\ M for 30 min fol lowed by the addition of 0.5 ml 2 X 
10- '\ M SP for another 30 min (net concentration of each 10- 4 M); 
or (4) 0.5 ml naloxone 2 X 10 -.1 M for 30 min followed by 0.5 
ml buffer for the remaining 30 min prior to aspiratio n and his-
tamine determinati on (Table f) . 
Histamine Assay The concentration of hista min e in superna-
tants was determin ed by th e automa ted Auo rim etric metho d of 
Siraganian (Alpkcm Histamine Autoanalyzer, C lackamas, O re-
gon). Substance P did not induce fa lse-positi ve readin gs on the 
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Figure 3. Effect of ca lciulll on SP (10 - 4 M)-induced HI< frolll hUlllan 
skin mast cell s. Points indicate mean ± SEM with the number of sa mples 
indicated in parentheses. 
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Table I. In fluence of Naloxone o n Substa nce P-Induced 
Histamine Release From a Human Skin Preparation 
Incubation 
Buffcr control 
N aloxone control (10 - 4 M) 
Substance P (10 - 4 M) 
Naloxonc (10 - 4 M) + Substance P (10 -" M) 
Histamine 
Release (%) 
2.5 
2.3 
13.2 
11 .3 
autoana lyzer. Assay specifici ty was confirmed by incubation with 
diam ine ox idase (Sig ma), w hich eliminated all detectabl e HR. For 
each assay, a standard curve was genera ted w ith histamine so-
lutions of known concentrations . 
RESULTS 
Substance P induced HR in a dose- dependent fas hion (Fig 1), 
peak in g at 25 .1 % w ith 5 X 10 - 4 M SP. Un fortunately, the 
un ava ilability of pure reagent precl uded incubations with higher 
concentrati ons of SP. 
T he time course of the HR reaction , using 10 - 4 M SP, is il-
lustrated in Fig 2. Nearly 80% of HR occurred w ithin 15 min 
and reached a platea u by 30 min . 
The effect of calcium on SP (10 - 4 M)-induced HR is shown in 
Fig 3. When in so lu tion with no added calcium , on ly 1.6% HR 
occurred; however, with increasing calcium concentration a dose-
response relationship was observed w ith ma ximal release of9.2% 
using 3 X 10 - 3 M calcium. Two specimens pretrea ted w ith EGT A 
(to chel ate int~acellul ar calcium stores) and subsequentl y incu-
bated w ith 10 -" M SP w ithout added calcium exh ibi ted no de-
tectable HR. 
T he effect of naloxone pretrea tm ent is summarized in Table I. 
Both buffer alone and naloxone 10 - 4 M all owed nearly identical 
HR (2.5% and 2.3% respectively). Substance P 10 - 4 M induced 
13.2% HR (n = 6) whereas SP added to cells already incubating 
in naloxone resu lted in 11.3% HR (n = 5) (d ifference not sig-
nificant). 
DISCUSSION 
Substance P induced HR from human skin mast cell preparations 
in a dose-dependent mann er. T hese results, similar to those re-
ported from experiments usin g rat peritoneal m as t cells [9,28-32), 
present th e first evidence for in vitro HR in human cutaneous 
tissue. 
Our results indica te that SP-induced HR is a calcium-dependent 
process. In cubatin g mas t cells in so lu tions devo id of calcium al-
lowed onl y negligible HR. In addition , w hen the cells were prein-
cubated in EGT A to chelate rem ai nin g intracellular ca lcium, no 
measurable release occurred. While it is conceivable that EGT A 
may have resu lted in direct inactivat ion of SP, and may not have 
exerted its effects through calcium chelation, these results are, 
nonetheless , consistent with the results of Fewtrell et al in w hi ch 
SP-induced HR is inhibited by pretreatment with ca lcium che-
lation of rat peritonea l mast cells [30]. 
Hi stamine release in our experiments was relatively rapid , w ith 
nea rl y 80% of hista min e bein g released within the first 15 min. 
At 30 min , release was maximal w ith no further in crease detected 
at 60 min. 
Preincubation w ith naloxone had no effect on release of his-
tamine. This is simi lar to experiments involving morphine-in-
duced HR [33,34]. If naloxone does have antagon istic effects with 
SP, they probably occur on central or peripheral nervous system 
levels, as we can provide no evidence of direct antagonistic ac-
tivity at the mast cell level. 
T he concentrat ion ofSP needed to elicit HR in our preparations 
was 10-100 times that required for most rat peritoneal mast cell 
studies. T his is probably at least partially due to suboptimal pen-
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etration and access of the neuropep tide because of the thickness 
of tissue slices (200 ,um) used in this technique. T his presents an 
obvious barrier to diffusion ofSP in to the tiss ue and, additionally, 
a barrier for hista mine egress in to the supernatant. Attempts at 
usin g th inner slices were unsuccessful , as these smaller fragm ents 
made the procedure technicall y impossible. Further studies usiIlg 
mast cells dissociated from hum an skin should allow for HR at 
much lower concentrations. In addition, in spite of frequent washes 
after ti ss ue sectioning, it is likely that proteases also con tributed 
to inactivation of SP, thus requiring hi gher concentrations of SP 
and lead ing to lower levels of H R. 
It is un known w hether these results can be generalized to adult 
foreskin or to skin from other body sites. While adult foreskin is 
highl y vascu lar, the spa rse vascul ar network in neonatal foreskin 
docs not m ature until 14-17 weeks postnata ll y [35]. In addition , 
beca use highl y vascu lar or sensitive tissues such as foreskin Con-
tain increased amounts of SP and/or histamine, these results m ay 
differ from those seen had other tissue been used [36]. 
O ur data suggest that the mechanism of SP-induced HR from 
hum an mast cells is energy requiring and calcium dependent, 
rather than cytotoxic . In Lagunoff and Mar tin's review of his-
tamine-releasing agents [37], they categorize SP as a mem ber of 
the po lybasic compounds, simil ar to polymyxin B, polyarginine, 
and compound 48/80 (a mixture of linear copolymers synthesized 
from p-methoxyphenethylmethylamine and formaldehyde). In 
experim ents w ith rat periton eal mast cells HR is parti ally depen-
dent upon the first 4 amino acids from the N-terminus in the SP 
molecule, w hich include the basi c amino acids arginine and lysine 
[30]. The ability of this peptide to cause HR could be related to 
the presence of these basic amino acids . Whether the event is 
receptor mediated remains to be determined. T he fact that an SP 
analog exhibi ts antagonist activity in rat peritoneal mast cells 
supports the possibility of receptor mediation [14]. 
Su bstance P could be involved in the pathogenesis of inflam-
matory skin diseases, prim aril y or secondari ly, in several different 
ways . Primary sensory neurons co uld be stimul ated antid romi-
ca ll y by trauma (e.g., itch, scratch , exco riations) , throug h in-
flamm atory mediators (e.g ., histamine), or conceivabl y even 
through a direct central/peripheral nervous sys tem pathway, al-
though as yet no such pathway is described . If such a pathway 
did exist, it might partiall y explain the effect of stress on exac-
erbations of certain inflammatory skin diseases (e.g., atopic d er-
matitis, psoriasis, urti ca ria), as has been suggested in recent ar-
ticles [8,38]. Antidromic release of SP could then induce HR of 
adjacent mast cells leadin g to inflammation and itch. Alterna-
tively , SP could be present in higher concentrations in the primary 
sensory neurons of these patients and /or could be released more 
readily . It is conceivable that the continual release of SP into the 
skin of these patients could account for the diminished flare re-
sponse to int radermal histami ne seen in patients w ith atopic der-
matitis [39] . Finall y, the quantity and releasability of SP m ay be 
normal in these patients but their mast cells m ay simpl y be overly 
sensitive to normal quantities of SP. 
One might argue that although we did obtain HR in our in 
vitro experim ent, the concentrations of SP needed for this release 
were too g reat to have physiologic significance. As stated pre-
viously, we believe the primary reason for needing such relatively 
high concentrations of SP is due to permea bility problems sec-
ondary to the size of th e tissue slices as w ell as the likely presence 
of tissue proteases. 
While plas ma levels of SP are estimated at 10 - 9 to 10 - 11 M 
[4,40]. it is the concentration of SP in and immediately around 
the involved sensory neurons that is critical. Although the actual 
concen tration ofSP w ithin primary sensory neurons is unknown, 
it is es timated to be in the micromolar range (Susan Leeman, 
Ph.D., personal communication, April 1, 1985) . If this is the case 
and there are mast cells adjacent to the region of SP release, it is 
quite possible that HR will occur. Several studies have shown 
intim ate relationships between mast cells and sensory neurons 
[41-43]. 
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In s ummary, we have show n that an in vitro preparation of 
human skin mast cells releases histamine in a dose-dependent 
fas hio n following exposure to sr. This release is ca lcium depen-
dent, rela tively rapid, and not antagonized by pret reatment w ith 
naloxo n e. 
The au th ors "' ish '0 ,hallk Cheryl C haney alld Sheri lIoss jor ,hcir exrcl/clI' 
secreta ria l assistall ce ill 'h e prepara,ioll of 'his llrallll seript. 
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